Resource Hub
Cytonics Selects CARA Life Sciences Platform for Rapid eTMF System Implementation
Cytonics, a biotechnology research and development company specializing in diagnostics and therapeutics for osteoarthritis, has selected Generis, the provider of the AI-enabled CARA Life Sciences Platform, to manage its electronic Trial Master File (eTMF) and enhance operational efficiency and productivity. Faced with a need for rapid implementation, Cytonics sought a
Kwizda Pharma Adopts CARA Life Sciences Platform for Rapid QMS Implementation with Minimal IT Resources
Kwizda Pharma, a division of Kwizda Holding GmbH and a leader in the Austrian healthcare market, has selected the CARA Life Sciences Platform from Generis, leading provider of CARA Platform for Content and Data management, to digitise and streamline Quality processes. With over 170 years of experience in the pharmaceutical
eTMF Archive on the CARA Life Sciences Platform
eTMF Archive on the CARA Life Sciences Platform The CARA Life Sciences Platform offers a comprehensive Electronic Trial Master File (eTMF) Archive, designed to enhance the management, accessibility, and compliance of your clinical documentation. By integrating advanced automation, seamless collaboration, and robust compliance features, CARA empowers life sciences companies to
Generis Introduces Game-Changing AI Capabilities in CARA 5.13 Release
LONDON, UK – 7th April 2025 – Generis, a global leader in content and data management, announces the release of CARA 5.13, the latest version of its industry-leading platform. This new release integrates cutting-edge artificial intelligence (AI) capabilities, including “Chat with Your Data,” an innovative feature designed to revolutionise how
Generis and Regenold Partner to Transform Regulatory and Quality Management in the Medical Device Industry
31/03/2025 – London UK – Generis, creator of leading life sciences platform CARA, and Regenold GmbH, a specialist in regulatory affairs and quality management for medical devices, have partnered to revolutionise the way medical device companies manage Regulatory Information and Quality. This strategic partnership will enable medical device organisations to
Cheplapharm: Pharma Company Unify Processes with the CARA Life Sciences Platform
500 Users Customer Since 2022 Data Management Cheplapharm Arzneimittel GmBH, headquartered in Greifswald, is a German pharmaceutical company that is successful in taking over well-known and well-established medicines from the research-based pharmaceutical industry. Get the Case Study
Accelerating AI Adoption in Life Sciences: An Interview with Peter Smedegaard Andersen of DAQUMA
Artificial intelligence is shaping the future of life sciences, offering opportunities to streamline processes, enhance regulatory compliance, and improve operational efficiency. However, despite the potential, AI adoption in the industry remains cautious, with organisations carefully assessing security, compliance, and return on investment before taking the next step. To explore the
Chemical Management on the CARA Life Sciences Platform
Chemical Management on the CARA Life Sciences Platform CARA streamlines the creation, storage, and lifecycle management of chemicals, raw materials, formulations, and packaging by integrating traceability, automation, and compliance tools, allowing full product management in one system. Download the Datasheet
